Dr. Eleni Andreopoulou, MD

Dr. Eleni Andreopoulou, MD

Save
Breast Oncology  |  
Female  |  
47 y/o
(28)

Accepting new patients

Dr. Eleni Andreopoulou, MD is a breast oncology doctor who practices in New York, NY. She is 47 years old and has been practicing for 23 years. Read her story

Weill Cornell Breast Center

425 E 61st St Fl 8

New York, NY 10065
Get Directions

Accepted insurance

  • Accepts most major Health Plans. Please contact our office for details.
  • Amerigroup (Wellpoint)
  • Blue Cross Blue Shield
  • CareSource
  • Cigna
  • Community Health Choice
  • Coventry Health Care
  • First Health (Coventry Health Care)
  • Guardian
  • Health Net
  • HealthPlus
  • HealthPlus Amerigroup
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana

Learn about Dr. Andreopoulou

Be confident in your decisions by checking out your provider's top areas of care, education, patient reviews and more. Learn about finding the right doctor for you

Video

Top Care Areas

new

See how frequently Dr. Andreopoulou performs your care needs compared to other doctors.

Breast Diseases
very high
more than 97% of peers
Breast Cancer
high
more than 82% of peers
Cancer
high
more than 78% of peers

Dr. Andreopoulou's percentages are based on the rate of treatment compared to peers nationwide from insurance data. Learn more info about our data and this Top Care Areas component.

We're trying something new with Top Care Areas.Was it helpful for you?YesNo

Dr. Andreopoulou's bio

This content was provided by Dr. Andreopoulou "Dr. Eleni Andreopoulou joined Weill Cornell Medical Center as an Associate Professor of Clinical Medicine specializing in the care and treatment of patients with breast cancer in January 2015. Prior to this appointment she held faculty positions at the Albert Einstein College of Medicine/ Montefiore Medical Center and the University of Texas M.D. Anderson Cancer Center. Dr. Andreopoulou completed her training in major academic institutions in both Europe and the U.S. After she completed her residency in Internal Medicine at St Bartholomew`s Hospital in London she was awarded a European Society of Medical Oncology fellowship and trained in Medical Oncology at the Royal Marsden Hospital/Institute of Cancer Research in London, UK. She received laboratory training in the signal transduction and molecular pharmacology laboratory studying correlations between drug sensitivity and constitutive gene expression gaining a unique learning experience in a model hybrid clinical/laboratory facility. Subsequently, she completed her fellowship in Hematology and Medical Oncology at the New York University School of Medicine. In addition to intensive and comprehensive clinical training this experience was key to her understanding of the complexities in preclinical and clinical evaluation of anticancer drugs and established a strong foundation in her career. In addition to her active clinical practice her strength to the Weill Cornell Medical Center team is her demonstrated passion for biomarker-driven clinical trials, pharmacogenomic predictors of chemoresistance, chemosensitivity, and endocrine sensitivity for early and advanced stage breast cancer. Most importantly, she conceptualized and established a prospective bio-repository in breast cancer providing a crucial foundation for precision medicine research. She assembled this multidisciplinary team effort at Einstein/Montefiore and in collaboration with scientists used the bio specimens to probe one of the most perplexing challenges in modern clinical oncology – the issue of drug resistance and its relationship to chemotherapy-mediated dormancy. At Weill Cornell Medical Center, Dr. Andreopoulou continues to actively facilitate the interface between basic and applied research, and has a special interest in individualized patient treatment. Her main research interest is biomarker-based patient selection in early phase development to fast track drug development of biologics and targeted therapy to effectively treat breast cancer while sparing patients from unnecessary toxicity. Her focus is next generation -oncology trials and incorporating technology in drug development. Her goal, in collaboration with scientists, is to explore the relationship between cancer treatment, neoplastic cells and the immune system in order to improve understanding of the determinants of response to therapy. This has the potential to contribute critical information for future testing of combinations of immunotherapy and chemotherapy in breast cancer treatment. She is an active investigator of several clinical trials of novel therapeutic approaches in advanced disease including her leadership role as a principal investigator in development of agents sponsored by the Cancer Therapy Evaluation Program at the National Cancer Institute. Dr. Andreopoulou has published over 40 peer review articles, reviews, editorials and book chapters and has been an invited speaker at international and national conferences. She is a member of several scientific organizations including the American Society of Clinical Oncology, the American Association of Cancer Research and the Royal Society of Medicine. She has also been active with Breast Cancer awareness programs covering screening and prevention with a particular focus on underserved minorities. She is also an active member of the American Women`s Medical Association. "

More

Read More

Care Philosophy

This content was provided by Dr. Andreopoulou ""I am a medical oncologist with an expertise in breast cancer medicine. My focus is the multidisciplinary care and treatment of patients, especially those who have tumors that are high risk. Because I am a passionate advocate of personalized medicine, my goal is to develop new successful treatments that exploit our knowledge of the cancer genome and the immuno cell network for immunotherapy, in order to improve the outcomes of breast cancer patients. To do this, I actively participate in team science and recognize the importance of establishing strong connections with other disciplines involved in the care of patients and who are in the laboratory, as our goals are the same- to cure breast cancer. I view my patients as individuals and welcome open and inclusive communication when discussing treatment strategies as it is paramount they feel comfortable with an established treatment pathway." "

More

Read More
2

Specialties

  • Breast Oncology
  • Medical Oncology
0

Board Certifications

Dr. Andreopoulou does not have any board certifications listed.

11

Conditions Treated

  • Acute Leukemia
  • Acute Lymphocytic Leukemia
  • All Lymphoma
  • Autoimmune Diseases
  • Brain Disorders
  • Breast Cancer
  • Breast Diseases
  • Cancer
  • Gynecologic Cancer
  • Purpura
  • Soft Tissue Sarcoma
1

Procedures

  • Chemotherapy

Background Check

0 Malpractice Claims

No malpractice history found for New York.

0 Sanctions

No sanctions history found for the years that Healthgrades collects data.

0 Board Actions

No board actions found for the years that Healthgrades collects data.

Education

  • University Of Ioannina
    Medical School | Graduated 1994
  • St. Bartholomew's Hospital and Royal London Hospitals
    Residency Hospital | Completed 2000
  • Nyu Langone Medical Center
    Fellowship Hospital | Completed 2008
  • Royal Marsden Hospital London, Uk
    Fellowship Hospital | Completed 2003
  • MD Anderson Cancer Ctr-U Tex
    Other Education | Completed

Awards & Recognition

Awards & Honors

Dr. Andreopoulou has no awards or honors listed.

Media & Publications

Dr. Andreopoulou has no media or publications listed.

Languages Spoken

  • English

Memberships & Professional Affiliations

Dr. Andreopoulou does not have any memberships or affiliations listed. If you are Dr. Andreopoulou and would like to add memberships or affiliations, please update your profile.

Dr. Andreopoulou's Reviews

Likelihood of recommending Dr. Andreopoulou to family and friends
4.4
based on 28 total reviews (1 with a comment)
Dr. Andreopoulou's Performance
  • Trustworthiness
    EXCELLENT
  • Explains condition(s) well
    EXCELLENT
  • Answers Questions
    EXCELLENT
  • Time well spent
    EXCELLENT
Office & Staff Performance
  • Scheduling
    EXCELLENT
  • Office environment
    EXCELLENT
  • Staff friendliness
    EXCELLENT
  • Average wait time
    16 to 30 minutes
Patient Comments (1)
in Brooklyn, NY |
Dr. A and her staff are very thorough, answered all my questions and made each experience very comfortable.
Have you seen Dr. Eleni Andreopoulou, MD?
Are you Dr. Andreopoulou?
Make it easy for patients to share their feedback. Also manage your personalized profile!

Visit Dr. Andreopoulou

Now Accepting New Patients
Dr. Andreopoulou accepts 27 insurance carriers
  • Accepts most major Health Plans. Please contact our office for details.
  • Amerigroup (Wellpoint)
    Medicaid
  • Blue Cross Blue Shield
    Blue Cross Blue Shield PPO
  • CareSource
    Medicaid
  • Cigna
    Great West Healthcare-Cigna PPO
  • Community Health Choice
    Medicaid
  • Coventry Health Care
  • First Health (Coventry Health Care)
    First Health (Coventry Health Care) PPO
  • Guardian
  • Health Net
    Medicaid
  • HealthPlus
    Medicaid
  • HealthPlus Amerigroup
    Medicaid
  • Horizon Blue Cross Blue Shield of New Jersey
    Medicaid
  • Humana
  • Husky Health
    Medicaid
  • inHealth
    Medicaid
  • INTotal Health
    Medicaid
  • Medicaid
  • Midwest Health Plan
    Medicaid
  • Molina Healthcare
    Medicaid
  • Peach State Health Plan
    Medicaid
  • Simply Healthcare Plans
    Medicaid
  • Staywell (Wellcare)
    Medicaid
  • UnitedHealthCare
    Medicaid
    United Healthcare
  • Wellcare of Georgia
    Medicaid
  • WellPoint
  • Worker's Compensation
    Worker's Compensation WC

*Please verify this information when scheduling an appointment.

Hospitals where Dr. Andreopoulou has admitting privileges

View Hospital Profile

More Oncology Specialists like Dr. Andreopoulou at Weill Cornell Breast Center

Breast Surgery Specialist
(5)